DE102006056783A1 - Zubereitung zur transdermalen Verabreichung von Galanthamin - Google Patents

Zubereitung zur transdermalen Verabreichung von Galanthamin Download PDF

Info

Publication number
DE102006056783A1
DE102006056783A1 DE102006056783A DE102006056783A DE102006056783A1 DE 102006056783 A1 DE102006056783 A1 DE 102006056783A1 DE 102006056783 A DE102006056783 A DE 102006056783A DE 102006056783 A DE102006056783 A DE 102006056783A DE 102006056783 A1 DE102006056783 A1 DE 102006056783A1
Authority
DE
Germany
Prior art keywords
galanthamine
preparation
transdermal
lecithin
transdermal administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102006056783A
Other languages
German (de)
English (en)
Inventor
Frank Becher
Thomas Dr. Hille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BECHER, FRANK, 56072 KOBLENZ, DE
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Priority to DE102006056783A priority Critical patent/DE102006056783A1/de
Priority to PCT/EP2007/010112 priority patent/WO2008064815A2/fr
Publication of DE102006056783A1 publication Critical patent/DE102006056783A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE102006056783A 2006-12-01 2006-12-01 Zubereitung zur transdermalen Verabreichung von Galanthamin Withdrawn DE102006056783A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE102006056783A DE102006056783A1 (de) 2006-12-01 2006-12-01 Zubereitung zur transdermalen Verabreichung von Galanthamin
PCT/EP2007/010112 WO2008064815A2 (fr) 2006-12-01 2007-11-22 Préparation pour l'administration transdermique de galanthamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006056783A DE102006056783A1 (de) 2006-12-01 2006-12-01 Zubereitung zur transdermalen Verabreichung von Galanthamin

Publications (1)

Publication Number Publication Date
DE102006056783A1 true DE102006056783A1 (de) 2008-06-05

Family

ID=39247230

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102006056783A Withdrawn DE102006056783A1 (de) 2006-12-01 2006-12-01 Zubereitung zur transdermalen Verabreichung von Galanthamin

Country Status (2)

Country Link
DE (1) DE102006056783A1 (fr)
WO (1) WO2008064815A2 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0521994B1 (fr) * 1990-03-29 1997-06-18 Skua Investments Limited Formulations pharmaceutiques
WO2001070206A2 (fr) * 2000-03-06 2001-09-27 Javor Andras Combinaison de medicaments
US6316428B1 (en) * 1995-03-10 2001-11-13 Wilson Trafton Crandall Topical moisturizing composition and method
US20050074487A1 (en) * 1999-12-16 2005-04-07 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
WO2005039531A1 (fr) * 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Formulation pharmaceutique transdermique visant a reduire les residus sur la peau
WO2005102268A2 (fr) * 2004-04-22 2005-11-03 Sanochemia Pharmazeutika Ag Inhibiteurs de la cholinesterase inclus dans des liposomes, leur production et leur utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030225031A1 (en) * 2002-05-21 2003-12-04 Quay Steven C. Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid
US20040185170A1 (en) * 2003-03-21 2004-09-23 Shubha Chungi Method for coating drug-containing particles and formulations and dosage units formed therefrom
US20080319092A1 (en) * 2005-08-05 2008-12-25 Nuvo Research Inc. Transdermal Drug Delivery Formulation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0521994B1 (fr) * 1990-03-29 1997-06-18 Skua Investments Limited Formulations pharmaceutiques
US6316428B1 (en) * 1995-03-10 2001-11-13 Wilson Trafton Crandall Topical moisturizing composition and method
US20050074487A1 (en) * 1999-12-16 2005-04-07 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
WO2001070206A2 (fr) * 2000-03-06 2001-09-27 Javor Andras Combinaison de medicaments
WO2005039531A1 (fr) * 2003-10-10 2005-05-06 Antares Pharma Ipl Ag Formulation pharmaceutique transdermique visant a reduire les residus sur la peau
WO2005102268A2 (fr) * 2004-04-22 2005-11-03 Sanochemia Pharmazeutika Ag Inhibiteurs de la cholinesterase inclus dans des liposomes, leur production et leur utilisation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HIRSCH MJ, GROWDON JH und WURTMAN RJ: "Relations Between Dietary Choline or Lecithin Intake, Serum Choline Levels and Various Metabolic Indices", In: Metabolism, Vol. 27(8), 1978, S. 953-960 *
WILLIAMS A: Transdermal and Topical Drug Drug Delivery, London, Chicago: Pharmaceutical Press, 2003, S. 9-13 und S. 102-106, ISBN 0-85369-489-3 *

Also Published As

Publication number Publication date
WO2008064815A2 (fr) 2008-06-05
WO2008064815A3 (fr) 2008-07-17

Similar Documents

Publication Publication Date Title
DE69129632T2 (de) Vorrichtung zum transdermalen verabreichen von medikamenten unter verwendung von sorbitanestern zum verbessern der hautdurchlässigkeit
DE69715049T2 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
DE69133123T2 (de) Vorrichtung zur transdermalen abgabe von annähernd gesättigten medikamenten mit erhöhtem medikamentenfluss
DE69326461T2 (de) Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
DE69326848T2 (de) Oxybutynin zur transdermalen Verabreichung
EP1178783B1 (fr) Dispositif et utilisation pour augmenter la permeation transdermique de medicaments
DE69916492T3 (de) Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen
EP1501499B1 (fr) Forme galenique transcutanee pour le traitement du syndrome des jambes sans repos
DE60100994T2 (de) Transdermales therapeutisches System für die Erzielung hoher Plasmaspiegel von Rotigotin in der Therapie von Morbus Parkinson
AT11185U1 (de) Transdermales therapeutisches system
DE3839410A1 (de) Mittel zur transdermalen verabreichung von wirkstoffen
DE4010079A1 (de) Pharmazeutische formulierung zur behandlung des alkoholismus
DE60311449T2 (de) Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen
DE4342174C1 (de) Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
DE102005050654A1 (de) Lippenpflaster
EP0584126B1 (fr) Substances facilitant la penetration
EP0781134A1 (fr) Emplatre a la scopolamine
DE3905051A1 (de) Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i)
DE19906979A1 (de) Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Nikotinabhängigkeit
EP1152763B1 (fr) Utilisation de la desoxypeganine pour le traitement de la toxicomanie
DE10340428B4 (de) Opioides Analgetikum enthaltende transdermale Formulierung
DE19834505A1 (de) Transdermales therapeutisches System zur Anwendung von Sildenafil
DE102006056783A1 (de) Zubereitung zur transdermalen Verabreichung von Galanthamin
EP1368023B1 (fr) Utilisation de buprenorphine pour traiter l'incontinence d'urine
EP2614820B1 (fr) Système thérapeutique transdermique doté d'un inhibiteur de la cholinestérase

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8127 New person/name/address of the applicant

Owner name: BECHER, FRANK, 56072 KOBLENZ, DE

8139 Disposal/non-payment of the annual fee